Efficacy of full-length parathyroid hormone PTH(l-84) in postmenopausal osteoporotic women through 24 months of treatment

被引：0
|
作者：
Roman-Ivorra, J. [1 ]
Comella, N. Fernandez-Llanio [1 ]
Chalmeta-Verdejo, C. [1 ]
Greisen, H. [2 ]
机构：
[1] Hosp Univ Dr Preset, Dept Rheumatol, Valencia, Spain
[2] NYCOMED AS, Dept Med, Roskilde, Denmark
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2007年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：532 / 532
页数：1
相关论文
共 50 条
  • [1] Bone turnover markers and BMD remain elevated in postmenopausal osteoporotic women through a full 24 months of treatment with human parathyroid hormone 1-84 (PTH).
    Greenspan, S. L.
    Hanley, D. A.
    Morris, S.
    Marriott, T. B.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S114 - S114
  • [2] Sequential treatment with full-length parathyroid PTH(1-84) of postmenopausal women with primary osteoporosis
    Felsenberg, D.
    Delmas, P.
    Hosking, D.
    Rizzoli, R.
    Brandi, M.
    Diaz-Curiel, M.
    Hyldstrup, L. H.
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2007, 80 : S126 - S126
  • [3] Full length parathyroid hormone, PTH(1-84), for the treatment of severe osteoporosis in postmenopausal women
    Adami, Silvano
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (11) : 3259 - 3274
  • [4] Safety and efficacy of 36 months treatment of postmenopausal osteoporotic women with PTH (1-84)
    Recker, R. R.
    Zanchetta, J. R.
    Mautalen, C. A.
    Man, Z.
    Leib, E. S.
    Morris, S. A.
    Greisen, H.
    Fox, J.
    [J]. BONE, 2009, 44 (02) : S431 - S431
  • [5] Update on the efficacy, safety, and adherence to treatment of full length parathyroid hormone, PTH (1-84), in the treatment of postmenopausal osteoporosis
    Pietrogrande, Luca
    [J]. INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2009, 1 : 193 - 203
  • [6] Full length parathyroid hormone (1-84) in the treatment of osteoporosis in postmenopausal women
    Jodar-Gimeno, Esteban
    [J]. CLINICAL INTERVENTIONS IN AGING, 2007, 2 (01) : 163 - 174
  • [7] Serum calcium values after 4 and 24 weeks of treatment with full-length parathyroid hormone PTH(1-84) of postmenopausal women with primary osteoporosis: The first 125 patients
    Diaz-Curiel, M.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S210 - S210
  • [8] Serum calcium values after one month's treatment with full-length parathyroid hormone PTH(1-84) of postmenopausal women with primary osteoporosis
    Hosking, D.
    Diaz-Curiel, M.
    Rizzoli, R.
    Delmas, P.
    Brandi, M.
    Felsenberg, D.
    Hyldstrup, L. H.
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2007, 80 : S130 - S131
  • [9] Recombinant Full-Length Parathyroid Hormone (1–84)
    Marit D. Moen
    Lesley J. Scott
    [J]. Drugs, 2006, 66 : 2371 - 2381
  • [10] A cost-utility analysis of full-length parathyroid hormone PTH (1-84)
    Belsey, J. D.
    Asmussen, M.
    Dalton, J.
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2008, 82 : S166 - S166
12345